Trending event
Nutter presents Acceleration 2015 Early Stage Life Sciences Conference
Print PDF
Nutter is presenting Acceleration 2015, the firm’s Early Stage Life Sciences Conference on November 11. This invitation-only event connects investors, entrepreneurs, and industry executives in biotechnology, pharmaceuticals, medical devices, and health IT who are focused on growth. Key thought leaders will examine the best paths to success in an active yet volatile market. An outstanding line-up of speakers will discuss current issues and trends in early-stage development among life science companies.
EVENT DETAILS:
Wednesday, November 11, 2015, 3:00 – 7:00 p.m.
Nutter McClennen & Fish LLP
Louis D. Brandeis Conference Center
155 Seaport Boulevard, Boston
KEYNOTE SPEAKER:
Omar Amirana, MD
Senior Vice President I Allied Minds
Panel I: Drugs, Devices and Diagnostics: Will the IPOs, M&As and investments continue?
Speakers:
Ben Dunn
Managing Director
Covington Associates
Bryan Giraudo
Managing Director
Leerink Partners
Paulina Hill
Principal
Polaris Partners
James Woods
Principal - Deals, Valuation
PwC - MoneyTree™ Life Sciences Report
Moderator:
Luke Timmerman
Founder & Editor
Timmerman Report
Panel II: Market Viability: What are the prerequisites for success?
Speakers:
PJ Anand
Founder, President & CEO
Alcyone Lifesciences
Luba Greenwood
Vice President, Global M&A and Business Development
F. Hoffmann-La Roche Diagnostics
Jason Hafler
Senior Director of Investments and Principal
Sanofi-Genzyme BioVentures
Moderator:
Jeremy Halpern
Partner, Emerging Companies
Nutter McClennen & Fish LLP
The program will be followed by cocktails, hors d’oeuvres and networking.
To view the full agenda for this invitation-only event, or request an invitation, click here.
